HEERLEN, The Netherlands – Royal DSM on Dec. 6 said it had completed its acquisition of Cargill’s cultures and enzymes business, which should boost DSM’s growth plans for its dairy business.
DSM’s portfolio of dairy ingredients now includes enzymes, polyunsaturated fatty acids, vitamins, cultures, probiotics and bio actives. DSM on Oct. 26 originally announced it had agreed to buy the Cargill business in an all cash transaction for €85 million.
Cargill’s cultures and enzymes operation also forms part of the company’s global texturizing business and employs roughly 200 people. The cultures and enzymes business has production facilities in Wisconsin and La Ferte-Sous-Jouarre, France. The market for cultures and enzymes is valued at more than €1 billion ($1.3 billion), growing steadily at more than 5 percent annually.